|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02161 JBM HEALTHCARE
Nominal 
2.660 -0.010 (-0.375%) | 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/09 HKD(K$) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | |
| Turnover | 429,644 | 7.693% | 398,953 | 326,828 | 236,848 | 189,372 |
| Cost of Sales | (176,043) | -8.817% | (193,065) | (155,706) | (151,305) | (114,292) |
| Gross Profit | 253,601 | 23.174% | 205,888 | 171,122 | 85,543 | 75,080 |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/09 HKD(K$) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 410 | -- | (245) | (930) | (1,035) | (1,034) | |
| Profit / (Loss) before Taxation | 146,933 | 24.118% | 118,382 | 80,734 | 28,657 | 11,180 | |
| Taxation | (26,274) | 37.517% | (19,106) | (16,200) | (5,556) | (2,905) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (5,648) | 66.362% | (3,395) | (2,073) | (1,540) | 1,765 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 115,011 | 19.952% | 95,881 | 62,461 | 21,561 | 10,040 | |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/09 HKD(K$) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | |
| Net Finance Costs / (Income) | 3,605 | 44.605% | 2,493 | 3,609 | 3,366 | 3,391 |
| Depreciation & Amortisation | 25,171 | 5.076% | 23,955 | 24,015 | 23,624 | 23,714 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/09 - Interim | %Chg (Compare to Interim) | 2024/09 | 2023/09 | 2022/09 | 2021/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/09 - Interim | %Chg (Compare to Interim) | 2024/09 | 2023/09 | 2022/09 | 2021/09 | |
| EPS (cts) | 14.120 | 21.410% | 11.630 | 6.870 | 2.410 | 1.120 |
| DPS (cts) | 9.750 | -- | 5.500 | 3.450 | 0.500 | 0.000 |
| Dividend Payout Ratio (%) | 69.051% | -- | 47.291% | 50.218% | 20.747% | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.303 | -- | 1.231 | 1.117 | 1.053 | 1.023 |
| Remarks: | Real time quote last updated: 15/12/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 115,011 |
| %Change | 19.952% |
| EPS / (LPS) | HKD 0.141 |
| NBV Per Share ($) | HKD 1.303 |